Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine.
Data(s) |
10/09/2015
10/09/2015
18/12/2014
|
---|---|
Resumo |
BACKGROUND Despite the progressive increase in life expectancy and the relationship between aging with multi-morbidities and the increased use of healthcare resources, current clinical practice guidelines (CPG) on cardiometabolic risk cannot be adequately applied to elderly subjects with multiple chronic conditions. Its management frequently becomes complicated by both, an excessive use of medications that may lead to overtreatment, drug interactions and increased toxicity, and errors in dosage and non-compliance. Concerned by this gap, the Spanish Society of Internal Medicine created a group of independent experts on cardiometabolic risk who discussed what they considered to be unanswered questions in the management of elderly patients. DISCUSSION Current guidelines do not specifically address the problem of elderly with multiple chronic conditions. For this reason, the combined use of the limited available evidence, clinical experience and common sense, could all help us to address this unmet need. In very old people, life expectancy and functionality are the most important factors for guiding potential treatments. Their higher propensity to develop serious adverse events and their shorter lifespan could prevent them from obtaining the potential benefits of the interventions administered. SUMMARY In this document, experts on cardiometabolic risk factors have established a number of consensual recommendations that have taken into account international guidelines and clinical experience, and have also considered the more effective use of healthcare resources. This document is intended to provide general recommendations for clinicians and to promote the effective use of procedures and medications. Journal Article; This expert panel project has been designed and supported by the Spanish Society of Internal Medicine (SEMI) members, and has been funded by the Boehringer Ingelheim-Lilly Alliance. |
Identificador |
Gómez-Huelgas R, Giner-Galvañ V, Mostaza JM, Cuende JI, de Miguel-Yanes JM, Rovira E, et al. Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine. BMC Cardiovasc Disord. 2014; 14(1):193 1471-2261 (Online) PMC4289584 http://hdl.handle.net/10668/1977 25519433 10.1186/1471-2261-14-193 |
Idioma(s) |
en |
Publicador |
BioMed Central |
Relação |
BMC cardiovascular disorders http://www.biomedcentral.com/1471-2261/14/193/abstract |
Direitos |
Acceso abierto |
Palavras-Chave | #Anciano #Enfermedades cardiovasculares #Complicaciones de la diabetes #Hipertensión #Enfermedades metabólicas #Evaluación nutricional #Obesidad #Prevención primaria #Factores de riesgo #Prevención secundaria #España #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged #Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Anticoagulants #Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Cardiovascular Agents::Antihypertensive Agents #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Monitoring, Physiologic::Monitoring, Ambulatory::Blood Pressure Monitoring, Ambulatory #Medical Subject Headings::Diseases::Cardiovascular Diseases #Medical Subject Headings::Diseases::Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications #Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Lipid Regulating Agents::Hypolipidemic Agents::Anticholesteremic Agents::Hydroxymethylglutaryl-CoA Reductase Inhibitors #Medical Subject Headings::Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension #Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases #Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Data Collection::Nutrition Assessment #Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Body Weight::Overweight::Obesity #Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Hematologic Agents::Platelet Aggregation Inhibitors #Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Services::Preventive Health Services::Primary Prevention #Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Services::Preventive Health Services::Secondary Prevention #Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/published Artículo |